These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 36218937

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Postacute Care for Medicare Advantage Enrollees Who Switched to Traditional Medicare Compared With Those Who Remained in Medicare Advantage.
    Huckfeldt PJ, Shier V, Escarce JJ, Rabideau B, Boese T, Parsons HM, Sood N.
    JAMA Health Forum; 2024 Feb 02; 5(2):e235325. PubMed ID: 38363561
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Evaluation of US Hospital Episode Spending for Acute Inpatient Conditions After the Patient Protection and Affordable Care Act.
    Ibrahim AM, Nuliyalu U, Lawton EJ, O'Neil S, Dimick JB, Gulseren B, Sinha SS, Hollingsworth JM, Engler TA, Ryan AM.
    JAMA Netw Open; 2020 Nov 02; 3(11):e2023926. PubMed ID: 33226430
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The effects of plan payment rates on the market for Medicare Advantage Dual-Eligible Special Needs Plans.
    McGarry BE, Layton TJ, Grabowski DC.
    Health Serv Res; 2019 Oct 02; 54(5):1137-1145. PubMed ID: 31111471
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Association of the Comprehensive End-Stage Renal Disease Care Model With Medicare Payments and Quality of Care for Beneficiaries With End-Stage Renal Disease.
    Marrufo G, Colligan EM, Negrusa B, Ullman D, Messana J, Shah A, Duvall T, Hirth RA.
    JAMA Intern Med; 2020 Jun 01; 180(6):852-860. PubMed ID: 32227133
    [Abstract] [Full Text] [Related]

  • 35. Assessment of Differences in Inpatient Rehabilitation Services for Length of Stay and Health Outcomes Between US Medicare Advantage and Traditional Medicare Beneficiaries.
    Cao Y, Nie J, Sisto SA, Niewczyk P, Noyes K.
    JAMA Netw Open; 2020 Mar 02; 3(3):e201204. PubMed ID: 32186746
    [Abstract] [Full Text] [Related]

  • 36. Did Medicare Advantage payment cuts affect beneficiary access and affordability?
    Skopec L, Aarons J, Zuckerman S.
    Am J Manag Care; 2019 Sep 01; 25(9):e261-e266. PubMed ID: 31518097
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Competitive bidding in Medicare Advantage: effect of benchmark changes on plan bids.
    Song Z, Landrum MB, Chernew ME.
    J Health Econ; 2013 Dec 01; 32(6):1301-12. PubMed ID: 24308881
    [Abstract] [Full Text] [Related]

  • 39. How do Medicare Advantage beneficiary payments vary with tenure?
    Jacobs PD, Molloy E.
    Am J Manag Care; 2017 Jun 01; 23(6):372-377. PubMed ID: 28817299
    [Abstract] [Full Text] [Related]

  • 40. Association of Participation in the Oncology Care Model With Medicare Payments, Utilization, Care Delivery, and Quality Outcomes.
    Keating NL, Jhatakia S, Brooks GA, Tripp AS, Cintina I, Landrum MB, Zheng Q, Christian TJ, Glass R, Hsu VD, Kummet CM, Woodman S, Simon C, Hassol A, Oncology Care Model Evaluation Team.
    JAMA; 2021 Nov 09; 326(18):1829-1839. PubMed ID: 34751709
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.